145 related articles for article (PubMed ID: 27488299)
1. Molecular Markers and Targeted Therapeutics in Metastatic Tumors of the Spine: Changing the Treatment Paradigms.
Goodwin CR; Abu-Bonsrah N; Rhines LD; Verlaan JJ; Bilsky MH; Laufer I; Boriani S; Sciubba DM; Bettegowda C
Spine (Phila Pa 1976); 2016 Oct; 41 Suppl 20():S218-S223. PubMed ID: 27488299
[TBL] [Abstract][Full Text] [Related]
2. Clinical Decision Making: Integrating Advances in the Molecular Understanding of Spine Tumors.
Goodwin CR; Abu-Bonsrah N; Bilsky MH; Reynolds JJ; Rhines LD; Laufer I; Disch AC; Bozsodi A; Patel SR; Gokaslan ZL; Sciubba DM; Bettegowda C
Spine (Phila Pa 1976); 2016 Oct; 41 Suppl 20():S171-S177. PubMed ID: 27488298
[TBL] [Abstract][Full Text] [Related]
3. Contemporary spinal oncology treatment paradigms and outcomes for metastatic tumors to the spine: A systematic review of breast, prostate, renal, and lung metastases.
Yao A; Sarkiss CA; Ladner TR; Jenkins AL
J Clin Neurosci; 2017 Jul; 41():11-23. PubMed ID: 28462790
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of clinical outcomes for patients diagnosed with skin cancer spinal metastases.
Goodwin CR; Sankey EW; Liu A; Elder BD; Kosztowski T; Lo SF; Fisher CG; Clarke MJ; Gokaslan ZL; Sciubba DM
J Neurosurg Spine; 2016 May; 24(5):837-49. PubMed ID: 26544595
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
6. The Targeted Therapies Era Beyond the Surgical Point of View: What Spine Surgeons Should Know Before Approaching Spinal Metastases.
Cofano F; Monticelli M; Ajello M; Zenga F; Marengo N; Di Perna G; Altieri R; Cassoni P; Bertero L; Melcarne A; Tartara F; Ducati A; Garbossa D
Cancer Control; 2019; 26(1):1073274819870549. PubMed ID: 31865766
[TBL] [Abstract][Full Text] [Related]
7. Postoperative quality-of-life assessment in patients with spine metastases treated with long-segment pedicle-screw fixation.
Bernard F; Lemée JM; Lucas O; Menei P
J Neurosurg Spine; 2017 Jun; 26(6):725-735. PubMed ID: 28338450
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment and outcomes of metastatic breast cancer to the spine.
Walcott BP; Cvetanovich GL; Barnard ZR; Nahed BV; Kahle KT; Curry WT
J Clin Neurosci; 2011 Oct; 18(10):1336-9. PubMed ID: 21782449
[TBL] [Abstract][Full Text] [Related]
9. Management of metastatic spinal column neoplasms--an update.
Araujo JL; Veiga JC; Figueiredo EG; Barboza VR; Daniel JW; Panagopoulos AT
Rev Col Bras Cir; 2013; 40(6):508-14. PubMed ID: 24573631
[TBL] [Abstract][Full Text] [Related]
10. Current paradigms for metastatic spinal disease: an evidence-based review.
Kaloostian PE; Yurter A; Zadnik PL; Sciubba DM; Gokaslan ZL
Ann Surg Oncol; 2014 Jan; 21(1):248-62. PubMed ID: 24145995
[TBL] [Abstract][Full Text] [Related]
11. Postoperative survival and functional outcomes for patients with metastatic gynecological cancer to the spine: case series and review of the literature.
Liu A; Sankey EW; Goodwin CR; Kosztowski TA; Elder BD; Bydon A; Witham TF; Wolinsky JP; Gokaslan ZL; Sciubba DM
J Neurosurg Spine; 2016 Jan; 24(1):131-44. PubMed ID: 26360144
[TBL] [Abstract][Full Text] [Related]
12. Approaching spinal metastases spread profile.
Amelot A; Terrier LM; Cristini J; LeNail LR; Buffenoir K; Pascal-Moussellard H; Bonaccorsi R; Mathon B
Surg Oncol; 2019 Dec; 31():61-66. PubMed ID: 31539643
[TBL] [Abstract][Full Text] [Related]
13. Surgical results of metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC): analysis of functional outcome, survival time, and complication.
Park SJ; Lee CS; Chung SS
Spine J; 2016 Mar; 16(3):322-8. PubMed ID: 26586194
[TBL] [Abstract][Full Text] [Related]
14. Complications of spine surgery for metastasis.
Igoumenou VG; Mavrogenis AF; Angelini A; Baracco R; Benzakour A; Benzakour T; Bork M; Vazifehdan F; Nena U; Ruggieri P
Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):37-56. PubMed ID: 31473821
[TBL] [Abstract][Full Text] [Related]
15. Current surgical management of metastatic spinal disease.
Gerszten PC; Welch WC
Oncology (Williston Park); 2000 Jul; 14(7):1013-24; discussion 1024, 1029-30,. PubMed ID: 10929589
[TBL] [Abstract][Full Text] [Related]
16. [Metastatic breast cancer in the spine : Molecular predictors for choosing adequate treatment strategies].
Adler D; Kriegsmann M; Sinn P; Schneeweiss A; Almansour H; Lehner B; Akbar M
Orthopade; 2018 Jul; 47(7):594-603. PubMed ID: 29487982
[TBL] [Abstract][Full Text] [Related]
17. Survival in breast cancer patients with spine metastases: Prognostic assessment involving molecular markers.
Amelot A; Terrier LM; Cristini J; Buffenoir K; Pascal-Moussellard H; Carpentier A; Bonaccorsi R; Le Nail LR; Mathon B
Eur J Surg Oncol; 2020 Jun; 46(6):1021-1027. PubMed ID: 31899046
[TBL] [Abstract][Full Text] [Related]
18. Prognostic scoring systems for spinal metastases in the era of anti-VEGF therapies.
Gregory TM; Coriat R; Mir O
Spine (Phila Pa 1976); 2013 May; 38(11):965-6. PubMed ID: 22648032
[TBL] [Abstract][Full Text] [Related]
19. Advances in the treatment of metastatic spine tumors: the future is not what it used to be.
Laufer I; Bilsky MH
J Neurosurg Spine; 2019 Mar; 30(3):299-307. PubMed ID: 30835704
[TBL] [Abstract][Full Text] [Related]
20. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
